Nisha Bansal

2 months ago | radcliffecardiology.com | James E. Udelson |Gregg W. Stone |Nisha Bansal |Antonio Ceriello

THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the Reprieve DMS.

2 months ago | radcliffecvrm.com | Steven Nissen |Nisha Bansal |Antonio Ceriello |David Wheeler

Is BMI the best indicator to identify CVD patients who can be treated with GLP-1 RAs and other weight management therapies? In this short interview, Dr Steven Nissen (Cleveland Clinic, Cleveland, US) discusses how to determine which CVD patients will benefit most from treatment with GLP-1 RAs. He highlights how lifestyle changes are often ineffective in achieving weight loss goals, and therefore, collaboration between healthcare specialists is necessary to provide the best treatment option.

2 months ago | radcliffecardiology.com | Gregg W. Stone |Nisha Bansal |Antonio Ceriello |David C. Wheeler

Video Published: Views: 14 Likes: 0 Average (ratings) THT Conference 2025 - Outcomes after heart failure patients were treated with an interatrial shunt show heart failure with reduced ejection fraction (HFrEF) patients had further benefit compared to heart failure with preserved ejection fraction (HFpEF) patients.